Despite their critical oncogenic role, KAT6A translocations are rare (< 1%), with the most frequent subtype, KAT6A-CBP(K/C), occurring in only 0.2–0.4% of AML cases [16, 17]. The gene discussed is CREBBP; the disease is acute myeloid leukemia.